Impact of treatment regimen with moroctocog alfa (AF‐CC) on bleeding rates in paediatric patients with severe haemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of treatment regimen with moroctocog alfa (AF‐CC) on bleeding rates in paediatric patients with severe haemophilia A

Published:2020-06-04 Issue:5 Volume:26 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Smith Mark P.¹^ORCID,Rupon Jeremy²^ORCID,Wali Yasser³^ORCID,Rimawi Hala⁴,Korth‐Bradley Joan²^ORCID,Smith Lynne²,Rendo Pablo²

Affiliation:

1. Canterbury Health Laboratories Christchurch New Zealand

2. Pfizer Inc Collegeville PA USA

3. Sultan Qaboos University Muscat Oman

4. King Abdullah University Hospital Irbid Jordan

Funder

Pfizer Canada

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14047

Reference8 articles.

1. Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII

2. BDDrFVIII (Moroctocog alfa [AF-CC]) for surgical haemostasis in patients with haemophilia A: results of a pivotal study

3. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs

4. The impact of prophylactic treatment on children with severe haemophilia

5. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP